Eli Lilly's breakthrough Alzheimer's drug

Reuters

Email Print

RELATED NEWS

 
 
New data from Eli Lilly shows that if used early enough, its experimental drug, solanezumab, slows down symptoms of Alzheimer's disease.

More Health News